You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Short-course radiotherapy followed by neo-adjuvant chemotherapy in locally advanced rectal cancer – the RAPIDO trial
|
|---|---|
| Published in |
BMC Cancer, June 2013
|
| DOI | 10.1186/1471-2407-13-279 |
| Pubmed ID | |
| Authors |
Per J Nilsson, Boudewijn van Etten, Geke AP Hospers, Lars Påhlman, Cornelis JH van de Velde, Regina GH Beets-Tan, Lennart Blomqvist, Jannet C Beukema, Ellen Kapiteijn, Corrie AM Marijnen, Iris D Nagtegaal, Theo Wiggers, Bengt Glimelius |
| Abstract |
Current standard for most of the locally advanced rectal cancers is preoperative chemoradiotherapy, and, variably per institution, postoperative adjuvant chemotherapy. Short-course preoperative radiation with delayed surgery has been shown to induce tumour down-staging in both randomized and observational studies. The concept of neo-adjuvant chemotherapy has been proven successful in gastric cancer, hepatic metastases from colorectal cancer and is currently tested in primary colon cancer. |
X Demographics
The data shown below were collected from the profiles of 18 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 5 | 28% |
| Spain | 2 | 11% |
| United Kingdom | 2 | 11% |
| Australia | 2 | 11% |
| Singapore | 1 | 6% |
| India | 1 | 6% |
| Unknown | 5 | 28% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 9 | 50% |
| Practitioners (doctors, other healthcare professionals) | 5 | 28% |
| Scientists | 3 | 17% |
| Science communicators (journalists, bloggers, editors) | 1 | 6% |
Mendeley readers
The data shown below were compiled from readership statistics for 246 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | <1% |
| Slovakia | 1 | <1% |
| Germany | 1 | <1% |
| Japan | 1 | <1% |
| Belgium | 1 | <1% |
| Unknown | 240 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 42 | 17% |
| Other | 29 | 12% |
| Student > Postgraduate | 25 | 10% |
| Student > Doctoral Student | 25 | 10% |
| Student > Ph. D. Student | 21 | 9% |
| Other | 51 | 21% |
| Unknown | 53 | 22% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 141 | 57% |
| Nursing and Health Professions | 5 | 2% |
| Agricultural and Biological Sciences | 4 | 2% |
| Immunology and Microbiology | 4 | 2% |
| Engineering | 4 | 2% |
| Other | 21 | 9% |
| Unknown | 67 | 27% |
Attention Score in Context
This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 February 2023.
All research outputs
#3,672,167
of 25,380,192 outputs
Outputs from BMC Cancer
#877
of 8,954 outputs
Outputs of similar age
#30,851
of 209,324 outputs
Outputs of similar age from BMC Cancer
#7
of 92 outputs
Altmetric has tracked 25,380,192 research outputs across all sources so far. Compared to these this one has done well and is in the 85th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,954 research outputs from this source. They receive a mean Attention Score of 4.8. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 209,324 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 85% of its contemporaries.
We're also able to compare this research output to 92 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.